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Abstract: The formation of the asymmetric left-right (LR) body axis is one of the fundamental aspects
of vertebrate embryonic development, and one still raising passionate discussions among scientists.
Although the conserved role of nodal is unquestionable in this process, several of the details around
this signaling cascade are still unanswered. To further understand this mechanism, we have been
studying Cerberus-like 2 (Cerl2), an inhibitor of Nodal, and its role in the generation of asymmetries
in the early vertebrate embryo. The absence of Cerl2 results in a wide spectrum of malformations
commonly known as heterotaxia, which comprises defects in either global organ position (e.g., situs
inversus totalis), reversed orientation of at least one organ (e.g., situs ambiguus), and mirror images
of usually asymmetric paired organs (e.g., left or right isomerisms of the lungs). Moreover, these
laterality defects are frequently associated with congenital heart diseases (e.g., transposition of the
great arteries, or atrioventricular septal defects). Here, reviewing the knowledge on the establishment
of LR asymmetry in mouse embryos, the emerging conclusion is that as necessary as is the activation
of the Nodal signaling cascade, the tight control that Cerl2-mediates on Nodal signaling is equally
important, and that generates a further regionalized LR genetic program in the proper time and space.
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1. The Development and Evolution of Left-Right Asymmetry
Most vertebrates are very active animals, which means they are high-energy consumption
organisms. In such demanding environments, the metabolic demand, as well as homeostasis of
tissues, had to be guaranteed, and this was attained through the generation of bigger organs [1]. As for
smartphones where the limits have to be pushed to package a growing number of features into a small
shell, the establishment of a left-right (LR) tissue patterning may have been crucial to accommodate
the increasing size of organs, and maintaining or even improving their physiological functions. Indeed,
it has been demonstrated that the spirally coiled heart has a higher pumping efficacy than linear tube
heart [2]. The outcome of such visceral structure can be translated into the rotation of the gut, the
anatomical difference of the lungs, the off-centered stomach, liver, spleen or pancreas. The initial event
in this process is cardiogenesis, as the heart is the first organ to be formed during embryo development.
It starts to exhibit asymmetry by looping asymmetrically and assuming a leftward tilted position in
the thoracic cavity, and it is also the first organ to be affected by LR mispatterning [3].
2. Left-Right Establishment
Like any other mechanism involved in the development of the vertebrate embryo, the
establishment of LR asymmetry requires a complex interplay of several molecular genetic pathways.
Although the understanding of how the LR axis is established has been the focus of several studies
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that go back to the 18th century, there is not a common model for the process. It is easy to enumerate
conserved but also divergent features in LR mechanisms of different animal models [4,5]. However,
there are three fundamental steps in the LR embryo patterning that are consensual in all models [4–10].
First, the initial bilateral symmetry breaking in the left-right organizer (the node in mice, or the
Kupffer’s vesicle in zebrafish), a transient structure at the posterior end of the notochord during
early somitogenesis. The second step is the propagation of the LR information generated on the node
to the mesodermal tissue at the periphery of the embryo, the lateral plate mesoderm (LPM), which
will trigger a LR asymmetric cascade of gene expression. The last step is the integration of the LR
signaling by the organ primordia and the translation of this information at the cellular level into the
asymmetrical growth of tissues, leading to the proper establishment of the organ morphology and
position in the body plan.
In the mouse, the hallmark on the establishment of the LR asymmetry is the expression of
Nodal, a secreted protein member of the transforming growth factor-beta (TGF-β) superfamily on the
left-lateral plate mesoderm (L-LPM). It was demonstrated that this expression of Nodal on the L-LPM
is a consequence, after symmetry breaking, of the upregulation of nodal signals on the left side of the
mouse node [11].
The mouse node is a temporary structure with a few hundred cells that it positioned between
the anterior notochord and the primitive streak in the ventral midline of the embryo during
early somitogenesis stages [12]. Although transient, the formation of this LR organizer is very
complex, dynamic, and dependent on the activity of several molecules, from transcription factors
(e.g., Brachyury) to extracellular matrix proteins (e.g., fibronectin), and signaling pathways (Nodal,
Planar Cell Polarity, Notch) [13–16]. Two types of cells compose the ventral mouse node, the pit cells,
which are columnar epithelial cells located in the central region of the ventral node, and the crown
cells, squamous epithelial cells located on the edge of the node [17–19]. Although both cell types are
monociliated, with 9 + 0 architectured cilia projected into the extraembryonic space, the cilia seem
to have different functions. Most of the cells in the central pit region possess motile rotating cilia
that are located on the posterior side of these dome-shaped cells. The clockwise strokes of these cilia,
which tilt towards the posterior side of the cavity, are responsible for the generation of a left-directed
extraembryonic fluid flow across the node. The crown cells of the mouse LR organizer have, in 90% of
cases, immotile cilia that seem to perceive, integrate, and process the direction and force of the fluid
flow. Therefore, it is conceivable that the LR asymmetric cascade of gene expression that governs
the further LR structural changes in the embryo starts in the node crown cells as a response to the
fluid flow. Because the direction of the fluid seems to be crucial, the leftward fluid flow is, under
proper conditions, the trigger for the asymmetric enhancement of Nodal expression on the left side of
the perinodal region of the ventral node, and subsequent downstream molecular activity of Nodal
signaling on the peripheral regions of the embryo.
3. Cerl2 Is Crucial to Tune Nodal’s Bioavailability to the Embryo
Cerberus-like 2 (Cerl2)/Dand5, is a secreted 20-kDa protein belonging to the family of
TGF-β/Nodal signaling antagonists Cerberus/DAN. Cerl2 is one of the key players in the initial
breaking of LR symmetry and on the control of the transmission of LR asymmetry information from
the node to the LPM (Figure 1) [20,21]. The significance of Cerl2 in the establishment of LR asymmetry
came to light when its expression was first detected in a horseshoe-shaped pattern in the perinodal
region of the mouse embryo at early head-fold (EHF) stage [22]. Although resembling the expression
of Nodal at this stage, Cerl2 mRNA assumes a complementary expression pattern to that of Nodal by
the early somitogenesis stage. Moreover, it was described that the Cerl2-mediated antagonism of nodal
signaling requires Cerl2 binding to the ligand Nodal, which consequently prevents the interaction of
Nodal with the receptor and subsequent signaling activation [22]. Therefore, at the time, the Cerl2
expression pattern and its Nodal inhibitory activity, together with the laterality defects observed in the
cerl2 KO mutants, placed Cerl2 as a protein at the proper time and place to be involved in LR symmetry
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breaking. More recently, it has been suggested that Cerl2 is the earliest gene to become asymmetric in
LR gene expression cascade [23]. This asymmetric expression of Cerl2 (L < R) seems to be established
as soon as the cilia at the node began to rotate generating a weak leftward flow. Curiously, in inv/inv
embryos the asymmetric expression of Cerl2 is reversed [24]. Moreover, it was observed that the L < R
asymmetry of Cerl2 is established in the perinodal crown cells, post-transcriptionally, by a robust decay
of the Cerl2 mRNA on the left side via its 3′-UTR [25].
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Figure 1. Sequential Nodal activity in left-right asymmetry at the mouse node during early
somitogenesis. Nodal expression is represented in light red oval, and Cerl2 expression in light green
oval. Cerberus-like 2 (Cerl2) protein is illustrated in green triangles, and the readout of Nodal signaling,
pSmad2/3, is indicated in red pentagons. The expression of Nodal in the lateral plate mesoderm (LPM)
of mouse embryos is represented by the filled red oval. Dashed to thicker lines indicate increase in
intensity. (A) At the one-somite stage, as soon as the cilia at the node began to rotate generating a weak
leftward flow, the asymmetric expression of Cerl2 (L < R) is established. This local reduction of Cerl2
mRNA (and Cerl2 protein) in the perinodal cells on the left side of the node results in an increase of
active Nodal signal, i.e., pSmad2/3. At the 2-somite stage, Cerl2 protein (green triangles) localizes and
prevents the activation of Nodal genetic circuitry on the right side of the embryo (dashed red oval).
Later, due to nodal flow, Cerl2 right-to-left translocation shutdowns Nodal activity in the node and
consequently affects the activity of Nodal in the LPM (dashed red oval). (B) In the absence of Cerl2 in
the node, the expression of Nodal in LPM becomes randomized.
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Although still unclear, several lines of evidence suggested that the initial generated fluid flow
is sensed via Pkd2, a Ca2+-permeable cation channel present in the immotile cilia of the perinodal
crown cells, and the subsequent flow-derived signal promotes the degradation or the instability of
Cerl2 mRNA [19]. In addition, it has been also suggested that is the Wnt-β-catenin mediated signaling
that regulates the asymmetric degradation of Cerl2 mRNA [25,26].
As mentioned above, the mouse LR organizer is a small but very a dynamic structure in which
each molecule seems to obey a strict script for a correct appearance on stage, both in space and
time. That is, the local reduction of Cerl2 mRNA (and Cerl2 protein) in the perinodal cells on the
left side of the node results in an increase of active Nodal signal, that is, in the phosphorylation
levels of Smad2/3 (pSmad2/3) at the one-somite stage [21,27]. This asymmetric distribution of
Cerl2 protein L < R precedes and causes the asymmetry in pSmad2 distribution, L > R. In addition,
Smad2/3 phosphorylation has a symmetrically distributed pattern in Cerl2 knock-out (KO) embryos,
highlighting once again the important role of Cerl2 in the induction of pSmad2 asymmetry.
Curiously, the fluid flow on the node not only produces an asymmetry of the distribution of Cerl2
mRNA but also of the Cerl2 protein. It was observed in mouse embryos that after its accumulation on
the right side of the node, Cerl2 protein displays a nodal flow-dependent right-to-left translocation at
the three- to four-somite stages [21]. The effect of the leftward fluid flow on the localization of Cerl2
protein was confirmed by the examination of embryos cultured in the presence of 1% methylcellulose,
which mechanically abolishes the ciliary motion and fluid flow. At the five-somite stage, Cerl2 protein
localizes preferentially on the left side of the node, exactly when Smad2/3 phosphorylation begins to
disappear. Therefore, after preventing any activity of Nodal on the right side of the node, the presence
of Cerl2 protein on the left side suppresses the activity of Nodal in the entire node.
Shortly after an L > R difference in nodal activity in the node is generated, Nodal becomes
expressed on the left side of the lateral plate mesoderm (L-LPM) [27]. Despite the fact that the presence
of Nodal protein in the node is a prerequisite for LPM gene expression, the transport of Nodal, whether
directly or not, has never been demonstrated and remains controversial. Nevertheless, several lines
of evidence suggest that Nodal might interact with Gdf1, and that sulfated glucosaminoglycans in
the extracellular matrix of the intervening tissue are most likely involved in the transport of this
complex [28].
The expression of Nodal on the left side of the LPM starts transiently in a small region adjacent
to the node (Figure 2), at the 2-somite stage, and then expands along the anterior-posterior (AP) axis,
disappearing by the 6-7-somite stage, lasting only several hours. For several years, it was considered
that this tight regulation was mediated by the action of Lefty (1 and 2) genes on the LPM. These genes,
Lefty 1/2, are direct targets of Nodal signaling and act as feedback inhibitors by competitive interaction
with the Nodal receptors/co-receptors [29–32]. When an active Nodal signal molecule reaches a certain
target region, it will promote the transcription of both Nodal and Lefty 1/2. Therefore, although Nodal
induces its own expression positively, it will also induce the expression of its negative regulators that
will eventually terminate the expression Nodal itself. This regulatory relationship between Nodal and
Lefty molecules is a well-known type of reaction-diffusion system, where the inhibitor diffuses more
rapidly than the activator, and constituting a self-enhancement lateral inhibition (SELI) system [33–35].
Lefty1 is predominantly expressed on the midline or prospective floor plate (PFP) and its expression is
also temporary, beginning at the 2-somite stage, near the node, expanding anteriorly, and disappearing
by the 5-6-somite stage [31,32,36]. Curiously, an ectopic expression of Lefty1 was seen on the node of
Cerl2 KO mutants, most probably due to an abnormal number of active Nodal molecules present on the
node in the absence of Cerl2 protein [24]. Lefty2 is expressed primarily in the left LPM restricting the
area of Nodal signaling to a particular region in the lateral tissue by the reaction-diffusion patterning
mentioned above [29,31,32].
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However, several observations in mouse embryos support the idea that by regulating the level of
active No al molecules in the n e, Cerl2 regulates the asymmetri p ttern of Nodal transmit ed to th
LPM and correct organ situs program: (1) The absence of Cerl2 in the node results in an upregulation
of Nodal signal and the sudden presence of Lefty1 expression in the node. This ectopic expression
of Lefty1 in the node causes a delay in the onset of Nodal program in the LPM [24]. (2) The local
post-transcriptional degradation of Cerl2 mRNA on the left side of the node, at the two-somite stage,
drives the L > R asymmetric distribution of phosphorylated Smad2/3 on the node that is subsequently
transduced in the L-LPM. This close correlation between the perinodal distribution of pSmad2/3 and
the expression of Nodal in the LPM is evident among several LR mutant mice observed [21,25,27].
(3) Simultaneously, at the two-somite stage, the accumulation of Cerl2 protein on the side of the node
prevents the activation of the Nodal cascade on the R-LPM, as predicted by the SELI system model
and observed on mouse embryos [21]. (4) The flow-dependent right-to-left translocation of Cerl2 shuts
down the Nodal activity on left side of embryo, that is, the presence of Cerl2 protein on the left side of
the nod by the 6-somite stage terminat s th transfer f laterality information to the left side f th
embryo and, as a consequence, the expression of Nodal in the LPM ceases [21,25,27]. (5) In the absence
of both of its inhibitors, in Cerl2/Lefty1 double KO embryos, Nodal activity increases and prolongs its
mRNA self-expression not only on the node but also in the LPM. The expression of Nodal is bilateral in
these mouse mutants, and begins much earlier, as soon as the 1-somite stage, and persists until the
6-somite stage [21,25,27].
4. Cerl2 and Cardiac Left-Right Development
As mentioned above, the initial LR axis determining event that will result in observable
morphological asymmetries is, in vertebrates, the establishment of a left identity which is granted
by the left-specific Nodal pathway, first on the node and subsequently transferred to the LPM. The
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asymmetric activation of this pathway on the left LPM is defined by the expression of Nodal, Lefty2,
and by the transcription factor Pitx2c in this lateral zone, with its anterior expression domains reaching
into the posterior primary heart field in cells that will be incorporated in the posterior part of primary
heart tube later, already with some LR identity cues [3].
Alterations in this asymmetric gene expression cascade will cause defects in the left-right
development of the organs, and it is known that the worst malformations are associated with
symmetrical rather than lateralized arrangement of the organs, this setting being associated with
the most complex cases of congenital heart defects (CHD) [37]. For example, the absence of Nodal’s
downstream effector gene, Pitx2c, will cause gut malrotation, right pulmonary isomerism, heterotaxy,
and a spectrum of cardiac defects [38–41]. Unlike Nodal, Pitx2c also has cardiac expression; in fact,
it is expressed in the heart tube in an asymmetric fashion, maintaining its left side exclusivity of
expression, which persists during looping stages until later stages [3]. Interestingly, as reported
for Nodal dosage-sensitive and concentration threshold dependent activity, the different levels of
expression of Pitx2 are also specific for different developmental processes. As seen by [40] the defects
in the Pitx2 KO can be rescued with hypomorphic Pitx2c alleles except for the right atrial isomerism,
which requires a higher dosage of Pitx2c expression/activity.
In the case of Cerl2 mouse mutants, we can observe a spectrum of asymmetry defects defined
as situs ambiguous, and a significant mortality rate within a few hours after birth due to cardiac
defects [22]. Some of these defects are laterality-associated ones affecting organogenesis and caused by
a multitude of LPM expression pattern combinations of Nodal and its downstream genes.
In fact, it seems that the absence of Cerl2 antagonism in the node will result in a dosage-dependent
randomization of Nodal signaling. Only relying on nodal fluid flow, the expression of Nodal in Cerl2
mutants is seen not only with the correct L-LPM expression pattern, but it is also observed in its inverse
(R-LPM-only expression, situs inversus), its absence (right isomerism), or its bilateral expression,
namely, both L- and R-LPM. Interestingly, in these last expressions, a certain degree of A-P differential
bilaterality of Nodal expression is commonly observed. That is, in some embryos bilaterality of LPM
expression is seen only near the node, and not more anteriorly or posteriorly, in other cases this
bilaterality is seen only more anteriorly in heart-field zones, and sometimes there is a full bilateral LPM
expression (left-isomerism) (Figure 2). This reflects the fact that the level of antagonism is required in an
exact time window, to regulate the necessary dose of Nodal activity in that time window, and these two
variables (time/dosage) will then influence the outcome of the pathway’s establishment significantly.
The end result in the case of Cerl2 mutants is a complex combination of phenotypes in which the
heart, and/or lungs are not correctly LR specified, but the gut can be looped correctly and stomach
correctly placed, or not [22].
The LR-derived organogenesis is accomplished in several ways from the two organ fields that
are initially present to either side of the midline, (or straight tubes on top of it) [3]: in the spleen,
only the left-side tissue completes differentiation [42], while in the heart tube, it will bend, twist and
remodel into its mature form with four chambers that no longer resemble the simple initial tube [43].
For directional looping initiation, several mechanisms have been proposed in different animal models:
in zebrafish, it was reported recently that expression of Prrx1a in higher levels on the R-LPM, drives
through a differential LR epithelial mesenchymal transition (EMT) and cell movements towards the
midline, to a leftward displacement of the cardiac posterior pole [44].
This asymmetric Prrx1 expression is, however, dependent on the master gene of the LR
determination, Nodal. In the mouse, this mechanism is proposed to have been replaced by Snail1 [44],
explaining the heart laterality phenotype observed in these mutants [45]. Taking into account these
new findings, it has been found that L-LPM Nodal is necessary to produce correct heart looping, but
this process might be controlled by both Nodal-dependent and -independent mechanisms [44,46].
In mice and, in particular, in Cerl2 mutants, which have a defective left-Nodal identity
establishment, looping defects are seen in 54% of embryos at E9.5 (L-, and ventral-looped hearts) [22].
It is well known that incorrect looping results in septation defects, and one such example of an
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incorrectly looped heart is shown in our mutants at a later stage, E11.5, in Figure 3. Atrial septal
defects have also been reported in our mouse mutants before [22]. Moreover, in agreement with the
mouse results, a variant in the functional domain of DAND5 protein (human Cerl2) has recently been
identified in our lab, in patients with both CHD and laterality defects [47].J. Cardiovasc. Dev. Dis. 2017, 4, 23 9 of 12 
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Figure 3. Incorrectly looped hearts in Cerl2 mutant embryos. Sagittal section of a wild-type (WT) (A)
and coronal section of Cerl2 mutant (B) hearts after looping stages, at developmental stage E11.5. These
sections made in different orientations (sagittal and coronal) show exactly the same anatomical features:
the common ventricular chamber (V) and span the outflow tract (OFT) and atrioventricular canal
(AVC) cushions of E11.5 mouse embryos. This shows that in the WT there was a correct rightward
(D-loop) (A), and in the mutant the looping occurred at a different angle, a leftward one (L-Loop)
(B). Embryo axes coordinates are present in panels A and B, in white letters: A: anterior; P: posterior;
R: Right, L: Left; D: Dorsal; V: Ventral.
Cerl2 is not involved in the looping process per se, only indirectly by influencing Nodal LPM
pathway program; and unlike Pitx2c, Cerl2 is not expressed in anterior L-LPM or in the primitive heart
tube at these stages; however, it will be expressed later on in the heart. In fact, we have uncovered
another expression stage for Cerl2 from E10.5 to E13 [48], although this expression is at a much lower
level than the one seen in t node at earlier stag s [22].
This later expression time window uncovered a role for Cerl2 during c rdiac development that is
independent of its function in the early events of LR asymmetry establishment [48]. We propose that
the cardiac malformations observed in Cerl2 null mice result from a combination of both disturbances
of laterality and of disruption of the contribution from intrinsic cardiac lineages independent from
laterality leading to increased interventricular septum (IVS) and left ventricle (LV) wall thickness.
In Cerl2 mutants, c rdiac development proc eds t the 4-chambered heart stage, but in so e cases
laterality efects such as ventricular s ptal defects are present.
The more striking cardiac malformation observed in Cerl2 KO neonates is the massive increase in
the left ventricular myocardial wall, with an increase in Ccnd1 gene expression, pSMAD2 signaling, and
Baf60c/Smarcd3 ratio in embryonic hearts. In accordance with our hypothesis that the overexpression of
Baf60c could mediate this phenotype, very recently it was reported that in Baf60c mutants, embryonic
hearts had a thin compact layer, and at E14.5 the ventricular walls were much thinner than WT [49].
Therefore, in addi ion to its involvem nt in the first step of asymmetry development, Cerl2 is also
required later in cardiac development, independently of its previously characterized role as a negative
regulator of the nodal pathway. Several mouse Cerl2 orthologues have been reported, and those that
show close similarities at the protein level are human DAND5 (p = 65%), CHARON in zebrafish
(p = 55%), Xenopus COCO (p = 53%), and chick CERBERUS (p = 51%). All these Cerl2 orthologues
have a conserved essential role in LR axis development [47,50–52], m reover, xCoco and zCharon have
been reported to shar two important characteristics with mCerl2: they display a right-sided bias
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of expression that responds to ciliary leftward-driven flow [53,54]. However, so far none of these
orthologues have been reported to have an independent role in cardiogenesis.
In summary, for the proper development of the anatomic asymmetries on the visceral organs,
and in particular in cardiac development, the intensity and duration of the asymmetric expression
of Nodal-Lefty-Pitx2c and further genetic programs must be restricted in time and space. Here, we
reviewed how, in mice, Cerl2 controls Nodal signaling at the node and the transmission of the LR
asymmetry information to the left-lateral plate mesoderm (LPM) in a precise time window, and how
this process is crucial for the correct positioning and anatomical development of the heart.
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